期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Molecular mechanisms of cisplatin resistance in ovarian cancer
1
作者 Chenying Jiang Chenjun Shen +5 位作者 maowei ni Lili Huang Hongtao Hu Qinhui Dai Huajun Zhao Zhihui Zhu 《Genes & Diseases》 SCIE CSCD 2024年第6期221-236,共16页
Ovarian cancer is one of the most common malignant tumors of the female repro-ductive system.The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy.As the most widel... Ovarian cancer is one of the most common malignant tumors of the female repro-ductive system.The majority of patients with advanced ovarian cancer are mainly treated with cisplatin-based chemotherapy.As the most widely used first-line anti-neoplastic drug,cisplatin produces therapeutic effects through multiple mechanisms.However,during clinical treat-ment,cisplatin resistance has gradually emerged,representing a challenge for patient outcome improvement.The mechanism of cisplatin resistance,while known to be complex and involve many processes,remains unclear.We hope to provide a new direction for pre-clin-ical and clinical studies through this review on the mechanism of ovarian cancer cisplatin resis-tance and methods to overcome drug resistance. 展开更多
关键词 CISPLATIN Drug resistance Molecular mechanisms Ovarian cancer Therapeutic strategies
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部